SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biochem Pharma (BCHE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Aggie who wrote (613)4/29/1999 10:35:00 PM
From: Richard Haugland  Read Replies (1) of 783
 
There have been a couple of small upticks in earnings estimates during the past week, including Cowan. Pennies but up.

Having beaten the same Q last year by 40% in both revenues and earnings should get BCHE some respect but it doesn't seem to. Looks like a longer term hold but it should eventually be a more secure investment that some of the alternatives. Much of the revenues increase, however, was from contract research. IMO, doubling the investment in research this Q versus a year ago should also pay dividends in the long run.

We'll see what the market says tomorrow. I would predict flat or down a buck or so nesr the opening (because everything I hold does that or worse) but eventually with some recovery over the next few weeks to a somewhat higher level (mid-20s). I would not expect any analyst upgrades or downgrades based on this and the analysts are already moderately bullish about the stock.

This stock has a LOT of shorts and one cannot always believe what one reads posted here or on Yahoo.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News